Cable Car Capital’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Hold
3,007,329
0.4% 44
2026
Q1
$13.5M Buy
3,007,329
+507,329
+20% +$2.54M 4.65% 4
2025
Q4
$13.2M Buy
2,500,000
+1,900,000
+317% +$9.56M 0.44% 15
2025
Q3
$3.17M Buy
+600,000
New +$3.81M 1.36% 14

Other funds holding ABEO

Cable Car Capital's ABEO Position: Q2 2026 in Review

Cable Car Capital held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 3,007,329 shares worth $18.6M. The position accounts for 0.4% of the portfolio, ranked #44.

Cable Car Capital first reported a position in ABEO in Q3 2025 and has held it in 4 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Cable Car Capital held 3,007,329 shares of Abeona Therapeutics worth $18.6M as of Q2 2026.
  • Cable Car Capital left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up 0.4% of Cable Car Capital's portfolio in Q2 2026, its #44 holding.
  • Cable Car Capital first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Cable Car Capital's 13F filing for Q2 2026, filed 14 Aug 2026.